Deutsche Bank analyst Dan Leonard raised his price target for Thermo Fisher (TMO) to $200 following his deeper look at the proposed Patheon (PTHN) acquisition. Cross-selling opportunities between the two companies do exist, but are difficult to quantify, Leonard tells investors in a research note. He keeps a Buy rating on Thermo shares.
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here